journal cover

Randomized, controlled chemoprevention trials in populations at very high risk for prostate cancer: Elevated prostate-specific antigen and high-grade prostatic intraepithelial neoplasia

Urology

Apr 1, 2001

Laura J Clark, James R Marshall

PMID: 11295623

Get paper from

Abstract

This is a report of research efforts underway at the Arizona Cancer Center. These efforts build upon Larry Clark's unanticipated clinical prevention trial results: those results indicated that 200 microg/day of selenium in selenized yeast decreased prostate cancer risk by almost 60%. Th...read more

Mentioned in this Paper

Prostatic Intraepithelial Neoplasias
Double-Blind Method
Selenomethionine, (S)-Isomer
Malignant Neoplasm of Prostate
Anticarcinogenic Effect
Malignant Neoplasm of Skin
Nutraceuticals
Pigmented Basal Cell Carcinoma
Prostate-Specific Antigen
Cervical Intraepithelial Neoplasia
Paper Details
References
  • References7
  • Citations20
1
  • References7
  • Citations20
12

Randomized, controlled chemoprevention trials in populations at very high risk for prostate cancer: Elevated prostate-specific antigen and high-grade prostatic intraepithelial neoplasia

Urology

Apr 1, 2001

Laura J Clark, James R Marshall

PMID: 11295623

DOI:

Abstract

This is a report of research efforts underway at the Arizona Cancer Center. These efforts build upon Larry Clark's unanticipated clinical prevention trial results: those results indicated that 200 microg/day of selenium in selenized yeast decreased prostate cancer risk by almost 60%. Th...read more

Mentioned in this Paper

Prostatic Intraepithelial Neoplasias
Double-Blind Method
Selenomethionine, (S)-Isomer
Malignant Neoplasm of Prostate
Anticarcinogenic Effect

Related Papers

Paper Details
References
  • References7
  • Citations20
1
  • References7
  • Citations20
12

Get paper from

/papers/randomized-controlled-chemoprevention-trials-in/11295623